Safely compounded medications are essential to quality patient care. Hospitals and clinics face the challenge of optimizing care while also meeting safety requirements and managing cost. Our team of experts will prepare you for compliance with USP Chapters 795, 797, 800 and 825. We’ll also assist you in preparing for inspections by the CMS, FDA, DEA, and Joint Commission. Visante can help evaluate external sources or show you how insourcing can give you increased control and positive ROI.
Our sterile compounding consulting services include:
- USP 795, 797, 800 and 825 consulting: Gap assessment and planning
- 503A, 503B and Home Infusion Compounding Services
- Facility design, including redesign, improvements or new design
- Improved operational policies and procedures
- Analysis of insourcing and outsourcing opportunities
When it comes to pharmacy compounding, we don’t settle for basic compliance—and you shouldn’t either. Our processes are designed to assist you and your team to be successful with providing the safest medications to your patients based on current standards and best practices. We help ease the compliance burden with the goal of exceeding administrative and safety goals for your patients.
The Visante team assisted us in conducting a USP 797 and 800 gap analysis across all our sterile compounding locations. The expertise and detailed knowledge they demonstrated provided very valuable information and action items. The Visante team helped educate our team about solutions and considerations for remodeling to meet not only the proposed guidelines and standards, but also future improvements incorporating best practices. The engagement was so successful we have decided to have the Visante team continue to assist us in our clean room design and implementation phases.